Access Consortium statement on COVID-19 vaccines evidence
The medicine regulators from Australia, Canada, Singapore, Switzerland and the United Kingdom (Access Consortium) have discussed the regulatory evidence requirements for COVID-19 vaccine approvals and considerations for post-market pharmacovigilance. This collective statement on COVID-19 vaccines builds on the Consortium's May 2020 pledge to work together to counter the COVID-19 global pandemic.
- Publisher - Current Organization Name: Health Canada
- Licence: Open Government Licence - Canada
Data and Resources
-
Access Consortium statement on COVID-19 vaccines evidenceHTMLEnglish publication HTML
-
Access Consortium statement on COVID-19 vaccines evidenceHTMLFrench publication HTML
Similar records